These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 11770910

  • 1. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.
    Stuetz A, Grassberger M, Meingassner JG.
    Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910
    [Abstract] [Full Text] [Related]

  • 2. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M, Steinhoff M, Schneider D, Luger TA.
    Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
    [Abstract] [Full Text] [Related]

  • 3. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
    Zuberbier T, Chong SU, Grunow K, Guhl S, Welker P, Grassberger M, Henz BM.
    J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
    [Abstract] [Full Text] [Related]

  • 4. Pimecrolimus permeates less than tacrolimus through normal, inflamed, or corticosteroid-pretreated skin.
    Meingassner JG, Aschauer H, Stuetz A, Billich A.
    Exp Dermatol; 2005 Oct; 14(10):752-7. PubMed ID: 16176283
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases.
    Hebert AA, Warken KA, Cherill R.
    Semin Cutan Med Surg; 2001 Dec; 20(4):260-7. PubMed ID: 11770913
    [Abstract] [Full Text] [Related]

  • 7. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG.
    Int Arch Allergy Immunol; 2006 Dec; 141(3):199-212. PubMed ID: 16926539
    [Abstract] [Full Text] [Related]

  • 8. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases.
    Lipozencić J.
    Acta Dermatovenerol Croat; 2005 Dec; 13(1):63-9. PubMed ID: 15788149
    [Abstract] [Full Text] [Related]

  • 9. Pimecrolimus 1% cream (Elidel) for atopic dermatitis.
    Bernard LA, Bergman JN, Eichenfield LF.
    Skin Therapy Lett; 2002 Apr; 7(4):1-3. PubMed ID: 12097994
    [Abstract] [Full Text] [Related]

  • 10. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 11. [Development and pre-clinical aspects of pimecrolimus].
    Stütz A, Grassberger M, Meingassner JG.
    Hautarzt; 2003 May; 54(5):405-12. PubMed ID: 12719859
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology.
    Meingassner JG, Grassberger M, Fahrngruber H, Moore HD, Schuurman H, Stütz A.
    Br J Dermatol; 1997 Oct; 137(4):568-76. PubMed ID: 9390333
    [Abstract] [Full Text] [Related]

  • 18. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation.
    Lerche CM, Philipsen PA, Poulsen T, Wulf HC.
    Exp Dermatol; 2009 Mar; 18(3):246-51. PubMed ID: 19183401
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.